BioInnovatise, Inc.

BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor and beyond. Our cloning and viral vector experts have advised and produced custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA. At BioInnovatise, we specialize in custom cloning services and products with a focus on the early stages of the drug discovery process.

Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to supporting researchers in their pursuit to make new breakthroughs in their respective fields.

BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. Our teams advise and produce custom projects that further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA.

We specialize in molecular biology products and services to advance research in the early discovery phases of cell and gene therapy, immunotherapy, precision medicine, regenerative medicine, stem cell research, and vaccine development.

Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to supporting researchers in their pursuit of making new breakthroughs in their respective fields.